The ODP can play an important role in characterizing the portfolio of prevention research funded by the NIH. Currently, NIH prevention research is identified based on a broad definition of prevention that does not provide sufficient detail to classify studies into categories of interest. New methods are needed that identify characteristics of studies—such as topic area, study design, population studied—and summarize the findings in a meaningful way for program planning and reporting. This more specific characterization of the prevention research portfolio, along with portfolio analysis tools, would enable identification of patterns and trends, as well as research areas that may benefit from targeted efforts by the NIH Institutes and Centers. Such categorization also would enable assessment of the progress and changes in prevention research over time.
The objectives supporting Strategic Priority I focus on the development of a taxonomy for prevention research that can be used to analyze the broader NIH portfolio. The ODP also will ensure that this process appropriately aligns with other efforts at the NIH, such as the Research, Condition, and Disease Categorization process. Furthermore, the ODP will work closely with colleagues in the NIH Office of Portfolio Analysis to apply existing approaches and develop new tools to improve our understanding of NIH prevention research investments. Using these tools, the ODP will perform portfolio analyses to characterize the NIH prevention research portfolio and develop products (e.g., reports) that can be shared with collaborators within and outside of the NIH. The ODP will examine historical and prospective information using the new portfolio analysis tools to analyze the progress of NIH prevention research.
- Objective I.1: Establish a taxonomy for prevention research that the ODP can apply to analyze the NIH prevention research portfolio.
- Objective I.2: Develop, test, and implement portfolio analysis tools to classify NIH awards based on the taxonomy for prevention research.
- Objective I.3: Develop and implement a process to regularly assess the progress and results of NIH investments in prevention research.